Recent Headlines
Within Pharmaceuticals
Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100
Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased to announce the completion of enrollment in MVT’s Phase 2 program using its microbubble product, MVT-100, for endocardial border delineation. This study, An Ascending Dose Comparison of... - September 13, 2024 - Microvascular Therapeutics, Inc.
Hemanext Inc. Announces New HCPCS Code for “Red Blood Cells, Leukocytes Reduced, Oxygen/Carbon Dioxide Reduced, Each Unit”
The Centers for Medicare & Medicaid Services (CMS) has officially issued a new Healthcare Common Procedure Coding System (HCPCS) code for “Red blood cells, leukocytes reduced, oxygen/carbon dioxide reduced, each unit,” an innovative blood transfusion product produced by the Hemanext ONE Red Blood Cell Processing and Storage System. - September 09, 2024 - Hemanext
MEDraysintell and NucAdvisor Join Forces to Expand Their Activities in Nuclear Medicine Consulting Services
MEDraysintell and NucAdvisor, an independent nuclear consulting company, subsidiary of Soletanche Freyssinet (VINCI Group), France, today announced the integration of the MEDraysintell business into NucAdvisor, including the brand and copyright assets. NucAdvisor will now assume responsibility for... - September 06, 2024 - MEDraysintell
Huntington Study Group and HD Genetics Collaborate to Better Serve HD Gene Positive Patients
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce a strategic partnership with HD Genetics to assist patients who have tested positive for Huntington’s disease (HD) learn about and enroll in research studies. There remains a... - September 05, 2024 - Huntington Study Group
Precision Medicine Hero Partners with MedTrait® and Dynamic DNA Laboratories to Deliver Pharmacy-Forward PGx Solutions to the Precision Medicine Provider Community
Precision Medicine Hero (PMH) announces a preferred partnership with pharmacist-forward precision medicine reporting platform MedTrait®, and pharmacogenetic (PGx) testing laboratory Dynamic DNA Labs, to facilitate their members’ access to advanced solutions for comprehensive PGx-guided medication management. - September 05, 2024 - Precision Medicine Hero
Ember Group Consulting Launches, Offering Transformative Solutions for Businesses
Ember Group Consulting LLC, a new global consulting firm specializing in organizational transformation and adaptive workforce solutions, officially launched today. The firm partners with visionary leaders to drive sustainable change and empower teams for peak performance. Leading Ember Group... - September 04, 2024 - Ember Group Consulting LLC
Size Stream Releases a New and Improved MeThreeSixty Mobile App
MeThreeSixty, the market-leading health and wellness app that enables users to track their body changes throughout their journey, now has an improved user experience and a Premium subscription option that provides unlimited access to 3D body scans and priority customer support. - September 04, 2024 - Size Stream
ALS Therapy Development Institute Commemorates 25th Anniversary at the Leadership Weekend in October
Taking place from October 3-5, 2024, in the Boston area, ALS TDI’s Leadership Weekend features a series of community-focused events, including an Open House at ALS TDI’s cutting-edge research lab, the ALS TDI Research Summit, and the White Coat Affair gala. - September 03, 2024 - ALS Therapy Development Institute
Driip IV Expands Into a Brand-New Space in Wayzata, MN; Offering Innovative IV Nutrient Therapy and Healing Services
Driip IV has moved to a beautiful space in Wayzata where they continue to offer cutting-edge services like IV nutrient therapy and other innovative treatments with a functional medicine approach. - September 02, 2024 - Driip
I Holland Launch Tool Room Layout Service
I Holland, a world leader in tablet tooling design and manufacturing, is thrilled to announce the launch of its new, bespoke tool room design service. - August 31, 2024 - I Holland Ltd.
New Partnership: Luminoso and KAPS Group
We are delighted to announce the partnership agreement between the KAPS Group, a long-time leader in text analytics/semantic AI consulting services for enterprise data-driven solutions, and Luminoso, a leading sentiment analysis company, whose Daylight software, a powerful but easy to use sentiment analysis tool. - August 29, 2024 - KAPS Group
The Future of Field Spectroscopy Keeps Growing
The future of field spectroscopy is now, and Spectral Evolution is growing their product offering. Spectral Evolution, the leading full range spectroradiometer manufacturer, is launching a new ultra-high-resolution, high-sensitivity, UV-VIS-NIR spectroradiometer, specifically engineered for fieldwork. The new NaturaSpec™ Ultra spectroradiometer offers the highest spectral resolution of any full range field spectroradiometer. - August 27, 2024 - Spectral Evolution
Right Enroll Introduces Comprehensive Medicare Plan Comparison & Selection Platform
Empowering Users to Make Informed Medicare Choices with Ease Right Enroll is happy to announce the launch of new Medicare Plan Comparison & Selection System which is aimed to help a client to find out how to choose the right Medicare plan according to his or her needs and peculiarities. Being... - August 24, 2024 - Right Enroll
NuSirt Health Launches LEUSIX™ Dietary Supplement into the Rapidly Growing GLP-1 Companion Product Market
NuSirt announces the launch of a unique patented supplement, with human clinical data of weight loss while maintaining lean body mass and improvement of cardiometabolic markers, that may be of interest to many, including those thinking of starting or stopping GLP-1 obesity drugs. - August 23, 2024 - NuSirt Sciences, Inc.
Official CelluCare Product Launch: Don’t Fall for Fake Websites
CelluCare, a leader in natural health supplements, announces the official launch of its newest product - a natural supplement designed to support healthy blood sugar levels. With increasing demand, concerns about counterfeit products being sold online have also risen. CelluCare advises consumers to purchase exclusively from the official website to ensure product authenticity and secure transactions, backed by a 60-day money-back guarantee. - August 21, 2024 - CelluCare
ICH1132 Shows Promise in Early-Stage Tumor Growth Inhibition Studies
New comparative study of ichorbio's anti-PD-1 antibody clone RMP1-14 highlights potential for optimized cancer research protocols. - August 21, 2024 - ichorbio Ltd
Huntington Study Group Announces New CEO
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive... - August 20, 2024 - Huntington Study Group
Hemanext Inc. Announces Completion of Cancer and Burn Safety Study, a Significant Milestone for the Hemanext ONE® Innovative Red Blood Cell Processing and Storage System
The post-market clinical study in Bergen, Norway, that was designed to assess the safety of transfusing hypoxic red blood cells (RBCs) in patients with acute burns and hematological malignancies, has been completed. - August 20, 2024 - Hemanext
Chartwell Launches New Ambulatory Infusion Suite in Oakdale, PA
Chartwell Pennsylvania, LP is proud to announce the launch of a new, nine-chair infusion suite, located in our Oakdale, PA headquarters. CHOICE by Chartwell provides a new alternative for patients to choose where they would like to receive their infusion therapy: at home, or at the new infusion Suite, located just minutes from Robinson Township and Pittsburgh, PA. The suite provides additional options for patients beyond physician offices or at their local hospital. - August 16, 2024 - Chartwell Pennslyvania, LP
VitaMist® Announces Exciting Competition: Win a Year’s Supply of Vitamins for You and a Friend
VitaMist®, a leader in Oral Spray Vitamins and Supplements, is thrilled to announce an exciting new competition offering participants the chance to win a year’s supply of vitamins for both themselves and a friend. - August 16, 2024 - VitaMist
Guides Collective Steps in Where Traditional Therapies have Failed with a Concierge Service to Match Seekers with Psychedelic Guides
Guides Collective launches psychedelic concierge service poised to become the "BetterHelp" of the psychedelic space. With over 600+ qualified psychedelic guides in their network, they work with you to find a psychedelic modality catered to a persons specific needs and desired outcome. - August 14, 2024 - Guides Collective
Evolution Analytics Expands with New Office in Durham, NC to Support Growing Demand for AI and Data Consulting Services
Strategic Expansion to Support Growing Client Demand and Leverage Top Tech Talent in the Raleigh/Durham Area - August 12, 2024 - Evolution Analytics
Californians Reject Board of Pharmacy’s Proposed Restrictions on Essential Alternative Medicines
Californians fight back against the Board of Pharmacy's proposed regulations that would severely restrict – and in many cases end – access to widely used sterile compounds like methylcobalamin (vitamin B12), glutathione, and NAD, easily accessible and legal in all 49 other United States. The Stop The BOP movement was formed in response, rallying significant public support to preserve access to these essential treatments. - August 08, 2024 - Stop The BOP
Parvus Therapeutics Announces Leadership Appointments to Support Development from Preclinical Into Clinical
New Positions Enhance Parvus Capability to Execute the Translation of Multiple Drug Candidates into the Clinic. - August 06, 2024 - Parvus Therapeutics U.S., Inc.
Pharma Lessons is Getting Ready for the Adoption of ICH E6 (R3)
In May 2023, the International Council for Harmonisation (ICH) released the third revision of the Good Clinical Practice E6 guidelines, replacing the E6 (R2) released in 2016. Currently, the document is published for public consultation. The purpose of this revision is to modernize the way... - August 06, 2024 - Pharma Lessons
Minus K Technology Announces Its Ninth Educational Giveaway of Vibration Isolators to U.S. Colleges and Universities
Minus K Technology announces its Educational Giveaway of Vibrations Isolators to U.S. Colleges and Universities. - August 05, 2024 - Minus K Technology Inc.
Creative Biolabs Spearheads Innovative Live Biotherapeutics Against Gut Diseases
Creative Biolabs introduces innovative solutions for live biotherapeutics to empower scientists and pharmaceutical companies in their quest for groundbreaking therapies against gut diseases. - August 03, 2024 - Creative Biolabs
Silver Scott Mines, Inc. Signs Letter of Intent to Acquire Innovative, Patented Non-Invasive Brain Treatment Technology
Silver Scott Mines will be acquiring the assets of AddBrain, Inc.’s technology. It has been used to treat Huntington’s Disease, Parkinson’s and Suicidal Depression with excellent results. There are ongoing clinical trials in Canada. - August 02, 2024 - Silver Scott Mines, Inc.
GENINVO, a Leading Provider of Innovations in Life Science Announced the Offering of Its On-Demand Service/Tool: DocQC
GENINVO has been working towards automating healthcare industry and contributing to faster drug discovery. GENINVO target to bring innovations as technologies, to automate the traditional and time-consuming process of Medical Writing. One example being, automating the process of clinical and... - August 02, 2024 - GenInvo, Inc.
New Study Explores Potential Benefits of Biophoton Generators in Alzheimer's Care
Study results shared at Alzheimer's Association International Conference in Philadelphia. - July 30, 2024 - Tesla BioHealing, Inc.
Parvus Therapeutics Has Received Orphan Drug Designation for Primary Biliary Cholangitis and Human Research Ethics Committee Approval to Begin Clinical Testing
Parvus Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PVT201 for the treatment of Primary Biliary Cholangitis (PBC) and PVT201 has obtained Australian Human Research Ethics Committee (HREC) approval to initiate a first-in-human... - July 29, 2024 - Parvus Therapeutics U.S., Inc.
Edison Agrosciences Announces $600,000 Seed Financing Round and Addition of Industry Veteran Tom Marsh to Board of Directors
Edison Agrosciences, an industrial biomaterials company developing a sustainable domestic source of natural rubber from sunflowers, today announced the closing of a $600,000 seed financing. - July 26, 2024 - Edison Agrosciences
Clinical Studies Highlight the Potential of Tesla BioHealing Biophoton Generator in Improving Mobility for Chronic Stroke Patients
Clinical studies indicate that the Tesla BioHealing® Biophoton Generator may help enhance mobility in patients with chronic stroke conditions. - July 24, 2024 - Tesla BioHealing, Inc.
Leap Years®: Supports Age-Related Cognitive Decline in Dogs and Quality Time Together with Owners Through NAD+ Enrichment
Animal Biosciences Announces Peer-Reviewed Publication of a Clinical Trial to Evaluate the Slowing of Age-Related Signs in Dogs. After five years of development, clinical results are published regarding senior dog aging in a rigorous, placebo-controlled trial performed at a North Carolina State University College of Veterinary Medicine. - July 23, 2024 - Leap Years
U.S. Precision Medicine, Inc. Signs MOU to Deploy microNeb’s VIGIL Series Inhaler Technology to Enhance Absorption of Its New Drug Candidate in IND Process
U.S. Precision Medicine, Inc. (USPM) has signed a Memorandum of Understanding (MOU) to deploy microNeb's advanced inhaler technology to expedite the uptake of its new cancer drug candidate currently in the Investigational New Drug (IND) process. - July 16, 2024 - microNeb, Inc.
MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy
Courage Therapeutics announced new evidence of synergy between MC4R agonists and GLP1RA drugs in a paper published in the Journal of Clinical Investigation led by co-founder Dr. Roger Cone. The company has completed a drug discovery campaign to invent a best in class portfolio of MC4R agonists for obesity in order to leverage the synergy. Potential combinations with drugs such as Ozempic and Mounjaro could improve side effects such as nausea and GI discomfort while driving increased weight loss. - July 16, 2024 - Courage Therapeutics
SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr. Donna Wilcock, to Its Scientific Advisory Board
SYNAPS Dx welcomes Dr. Donna M. Wilcock, a leading Alzheimer's researcher, to its Scientific Advisory Board. Dr. Wilcock's expertise in neuroinflammation and vascular cognitive impairment will support the advancement of the DISCERN™ diagnostic test for Alzheimer's disease. This addition reinforces SYNAPS Dx’s commitment to pioneering accurate, minimally invasive diagnostics for Alzheimer's. For more info, visit SYNAPS Dx's website. - July 15, 2024 - SynapsDx
Huntington Study Group Announces Launch of LEAD-HD Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) today announce the release of their newest Patient Reported Outcomes (PRO) study, LEAD-HD. This observational study was developed collaboratively with the University of Rochester Center for Health +... - July 15, 2024 - Huntington Study Group
GDP Training Course is Now Ready and Free
Pharma Lessons’ new GDP training is finally out. It covers the guidelines for wholesale distribution of medicinal products as an important part of the supply chain management. The course is a summary of the most recent GDP (Good Distribution Practice) guidelines based on Articles 84 and... - July 15, 2024 - Pharma Lessons
NuvOx Pharma LLC Announces Authorization of ARDS Trial from Health Canada
NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND: novEl oXygen ThErapeutic NanO2 for mild respiratory distress in Phase Ib and ARDS in Phase II Trials. Evan Unger, MD, CEO of NuvOx, said, “Acute Respiratory Distress... - July 12, 2024 - NuvOx Therapeutics
LGBTQ+ Screenplay Shining Light on Opioid Crisis Unveils Title & New Website
Multi-award winning film script has a new title and a new website to promote the message of hope. Inspired by true events, the screenplay depicts the harsh realities of opioid addiction and the challenging road to recovery those struggling must face. - July 02, 2024 - Worthy
Tesla BioHealing, Inc. Achieves ISO 13485 QMS Certification
Tesla BioHealing, Inc. manufactures unique wellness devices while using a quality management system recently certified by American Systems Registrar (ASR). - July 01, 2024 - Tesla BioHealing, Inc.
igus® Presents a Unique 4-Year Guarantee for Their Products
Even greater operational reliability and sustainability thanks to billions of test cycles in their in-house laboratory. - June 28, 2024 - igus Singapore Pte Ltd
Abel Womack CEO Announces His Retirement and Successor
After 50 years with Abel Womack, John Croce, CEO retires. - June 27, 2024 - Abel Womack Inc
Daicel Arbor Biosciences Launches New myTXTL® Kits to Accelerate Protein Expression
Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering. These powerful new kits include the myTXTL Pro Kit and the myTXTL Antibody/DS... - June 27, 2024 - Daicel Arbor Biosciences
Natural Scientific Launches Amazon Storefront to Revolutionize Nutritional Supplement Market
Privately-owned American company introduces a new range of natural, filler and additive-free vitamins and minerals. - June 26, 2024 - Natural Scientific Labs LLC
SYNAPS Dx Announces Expansion to New, State-of-the-Art Facility
SYNAPS Dx has moved to a new, state-of-the-art facility in Rockville, MD, to meet growing demand and enhance patient care. The larger space and advanced infrastructure will support more diagnostic samples and ensure timely, accurate Alzheimer's and dementia diagnoses. Fully qualified for high-complexity clinical lab testing, the facility boosts diagnostic capabilities. The expansion will also advance the DISCERN™ test, a minimally invasive tool distinguishing Alzheimer's from other dementias. - June 26, 2024 - SynapsDx
Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science
Cambridge Polymer Group (CPG) announced a new leadership structure to better support clients in developing innovative products. CPG is creating a new five-person senior management team with deep materials science expertise, which will allow for closer collaboration with clients on complex projects. Dr. Gavin Braithwaite will be the new CEO and Dr. Stephen Spiegelberg will move to the new role of Chief Scientific Officer (CSO). - June 23, 2024 - Cambridge Polymer Group
I Holland Launches Tooling Safe Disposal & Recycling Service
I Holland, has launched its new Safe Disposal &Recycling Service. This valuable service is designed to ensure the safe, secure, and environmentally responsible destruction of obsolete or worn-out tooling, enhancing both the integrity and sustainability of pharmaceutical manufacturing. Their... - June 23, 2024 - I Holland Ltd.
VITAMIST® Unveils New Enhanced Website for Premium Vitamin Oral Sprays
VITAMIST®, inventor of vitamin oral sprays, is excited to announce the launch of its newly redesigned website, www.vitamist.com. This significant update underscores VITAMIST's commitment to providing high-quality, science-backed vitamin solutions. - June 13, 2024 - VitaMist